English
Polski
Español
українська
The 3 most important recent advances in gastroenterology
Dr Paul Moayyedi, professor of medicine from McMaster University, shares his views on the 3 most important recent advances in gastroenterology.
2021-08-11
Dr Paul Moayyedi, professor of medicine from McMaster University, shares his views on the 3 most important recent advances in gastroenterology.
Is fecal microbiota transplantation (FMT) going to be performed for indications other than Clostridium difficile infection (eg, alcoholic steatohepatitis, obesity, inflammatory bowel disease [IBD])?
Can the gut microbiota lead to diseases (eg, cirrhosis or obesity)?
Is an abnormal gut microbiota a cause or consequence of inflammatory bowel disease (IBD)?
What effect do probiotics have on the gut microbiota?
What aspects of diet are beneficial for the gut microbiota?
What follow-up tests, if any, should be performed in a patient with Crohn disease who is in clinical remission?
How long should maintenance treatment be used in an asymptomatic patient with inflammatory bowel disease (IBD)? What tests should be performed before treatment discontinuation?
What are the risks associated with biologic therapy in patients with inflammatory bowel disease (IBD)? Can they be avoided?
How to monitor a patient with inflammatory bowel disease (IBD) receiving long-term treatment with azathioprine or 6-mercaptopurine (6-MP)?
